What has changed is the size of the audience that needs it and the urgency of the timeline
Instructions foronline consultation
Overall prescribing trends The study found that 2,454,615 patients were prescribed a GLP-1 RA between January 2018 and September 2025, with 12,203,009 total prescriptions during this period
Reported spending shifts toward wellness and lifestyle Across both markets, GLP-1 users in this study report shifting spending away from restaurants and indulgent categories and toward clothing, fitness, personal care, and health-related products
B12 Skinny Shot is $35 per shot
Statins remain first-line treatment for elevated cholesterol, with GLP-1 therapy providing complementary cardiovascular benefits